Navigation Links
DrugNews Update: Merck Files Challenge Over Plans For Generic NuvaRing
Date:1/11/2014

Chicago, IL (PRWEB) January 11, 2014

The birth control resource center at DrugNews.net has added new information for those patients using the contraceptive NuvaRing. The maker of the device, Merck, recently challenged another company’s plans to market a generic version in upcoming years*.

DrugNews is a patient resource center offering the latest news, safety alerts, product recalls and litigation updates on popular prescription drugs. Visitors can see if others are experiencing similar side effects, avoid potential dangers and decide if they need legal advice.

NuvaRing is a small plastic contraceptive insert approved by the FDA for sale in the United States in 2001. Today it is marketed in over 50 countries and used by an estimated 1.5 million people worldwide**.

DrugNews has uncovered health warnings from experts such as the New England Journal of Medicine showing vaginal ring contraceptives like NuvaRing may result in a 6.5 times increased risk of blood clots***.

Now, The resource center has learned NuvaRing maker Merck has filed suit against rival drug company Actavis over allegations that it marketed plans to release a generic version of NuvaRing prior to the expiration of Merck’s patent in 2018*.

According to court records, a number of women have already filed a NuvaRing lawsuit against Merck alleging blood clots from the device, with cases consolidated to a special federal multidistrict litigation court. The formal case is In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri. The latest court records show 1,610 cases filed as of December 16****.

Anyone who suffered a blood clot, stroke, DVT or pulmonary embolism after using NuvaRing is urged to visit DrugNews or speak with a lawyer about their legal rights as soon as possible. DrugNews only recommends lawyers who have already handled NuvaRing lawsuits.

For more information on the research, side effects and litigation news related to NuvaRing and other drugs, or to speak with a lawyer, visit http://www.DrugNews.net.

*Bloomberg, 12/24/13; bloomberg.com/news/2013-12-24/merck-sues-actavis-unit-over-patent-for-generic-nuvaring.html; Merck Sharp & Dohme BV v. Warner Chilcott Co., U.S. District Court, District of Delaware (Wilmington).
**Huffington Post, 12/18/13; huffingtonpost.com/2013/12/18/nuvaring-blood-clots_n_4461429.html
***New England Journal of Medicine, 6/14/12; nejm.org/doi/full/10.1056/NEJMoa1111840
****Judicial Panel on Multidistrict Litigation, 12/16/13; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-December-16-2013.pdf

Read the full story at http://www.prweb.com/releases/2014-generic-nuvaring/lawsuit-claims/prweb11482089.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugNews Alerts of Court Records Showing Rise In Mirena IUD Complaints
2. DrugNews: Latest Info Shows Rise in NuvaRing Lawsuits Alleging Blood Clots
3. DrugNews: Federal Court Moves Growing Mirena Lawsuits Forward
4. DrugNews: Pradaxa Study Reveals Stroke, Bleeding and Heart Attack Risks In Some Patients
5. DrugNews: Court Records Show Growth In Claims Alleging Pradaxa Bleeding Injury
6. DrugNews: Judge Refuses Bayer Request to Dismiss Mirena Lawsuit
7. DrugNews Adds Latest Court Update on Januvia Lawsuits
8. DrugNews Announces Launch of Topamax Resource Center for Birth Defects
9. HRT Update: Therapy May Reduce Fractures, Boost Some Risks
10. Transvaginal Mesh Lawsuit Update: New Study Concerning Use of Vaginal Mesh in Prolapse Procedures, Bernstein Liebhard LLP Reports
11. Cell Phone Radiation Lawsuit Update: ICEMS Position Paper Supports Italian Supreme Court Ruling on Cell Phones and Brain Tumors, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ... Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate ... primary prevention of cardiovascular diseases during the 15th Annual Women’s Health Conference. ...
(Date:10/13/2017)... , ... October 13, 2017 , ... The Visiting Nurse ... Market. Featuring a collection of specialty vendors and unique items from across the nation, ... quality-focused health and wellness services offered by the VNA. The boutique will be ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, ... lowdown on sciatica in a new episode of "Success Files," which is an ... and innovation and investigates each subject in-depth with passion and integrity. , Sciatica ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance ... management, will showcase a range of technology and learning solutions at the 68th ... and Expo to be held October 14–18, 2017 at the Mandalay Bay Resort ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... introduction of an innovative new design of the shoulder pad. The shoulder pad ... comfort while controlling your pain while using cold therapy. By utilizing ice and water ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Oct. 2, 2017 The Rebound mobile app is ... to reverse the tide of prescription drug addiction. The app ... medicine intake and stepping down their dosage in a safe, ... in December 2017; the first 100,000 people to sign up ... http://www.rebound-solution.com/ ...
(Date:9/27/2017)... 27, 2017  Commended for their devotion to personalized service, ... as number one in the South Florida Business Journal,s 50 ... 5000 yearly list, the national specialty pharmacy has found its ... will soon be honored by SFBJ as the 2017 ... Set to receive his award in October, Bardisa said ...
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
Breaking Medicine Technology: